- Home
- Urologic Oncology
- CRPC w/ bone metastases
CRPC w/ bone metastases
Recent Abstracts
-
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.CRPC w/ bone metastasesJuly 15, 2017
-
Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer.CRPC w/ bone metastasesMay 31, 2017
-
An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223.CRPC w/ bone metastasesMay 1, 2017
-
Doped silica fibre thermoluminescence measurements of radiation dose in the use of (223)Ra.CRPC w/ bone metastasesApril 28, 2017
-
Management of metastatic castration-resistant prostate cancer: A focus on radium-223: Opinions and suggestions from an expert multidisciplinary panel.CRPC w/ bone metastasesApril 25, 2017
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CTCRPC w/ bone metastasesApril 7, 2017
-
Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models.CRPC w/ bone metastasesApril 2, 2017
-
The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II).CRPC w/ bone metastasesMarch 27, 2017
-
Impact of locally advanced or metastatic prostate cancer on the quality of life.CRPC w/ bone metastasesMarch 7, 2017
-
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multi center database- AbstractCRPC w/ bone metastasesMarch 7, 2017
Beyond the Abstracts
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015
E-Newsletters